Cart
sales@molnova.com
SF-22
CAS No. 824981-55-7
SF-22( —— )
Catalog No. M36383 CAS No. 824981-55-7
SF-22 is a neuropeptide Y receptor (Y2R) antagonist that crosses the blood-brain barrier and has potential anti-inflammatory activity for the study of diseases associated with neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | Get Quote |
|
| 5MG | 65 | Get Quote |
|
| 10MG | 107 | Get Quote |
|
| 25MG | 227 | Get Quote |
|
| 50MG | 364 | Get Quote |
|
| 100MG | 566 | Get Quote |
|
| 500MG | 1161 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSF-22
-
NoteResearch use only, not for human use.
-
Brief DescriptionSF-22 is a neuropeptide Y receptor (Y2R) antagonist that crosses the blood-brain barrier and has potential anti-inflammatory activity for the study of diseases associated with neurological disorders.
-
DescriptionSF-22 is a neuropeptide Y receptor (Y2R) antagonist that crosses the blood-brain barrier and has potential anti-inflammatory activity for the study of diseases associated with neurological disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetNeuropeptide Y Receptor
-
RecptorNeuropeptide Y Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number824981-55-7
-
Formula Weight470.58
-
Molecular FormulaC28H26N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC(NS(=O)(=O)C2=C(C)C=CC(=C2)C(=O)NC2=CC=CC=C2C2=CC=CC=C2)=C(C)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MK-0557
MK-0557 is a selective and orally available antagonist of the neuropeptide Y5 receptor (Ki: 1.6 nM).
-
[Leu31,Pro34]-Neurop...
High affinity neuropeptide Y Y1 receptor agonist (Ki = 0.39 nM). Also shows affinity for Y4 and Y5 receptors.
-
Neuropeptide SF (mou...
Neuropeptide FF receptor agonist (Ki values are 48.4 and 12.1 nM for NPFF1 and NPFF2, respectively). Potentiates the antinociceptive action of morphine in vivo and reverses the loss of morphine potency in tolerant animals. Also increases the amplitude of the sustained current of heterologously expressed acid sensing ion channel 3 (ASIC3) (EC50 ~ 50 μM).
